Optimization of Potent and Selective Tricyclic Indole Diazepinone Myeloid Cell Leukemia-1 Inhibitors Using Structure-Based Design.

MLA

Shaw, Subrata, et al. “Optimization of Potent and Selective Tricyclic Indole Diazepinone Myeloid Cell Leukemia-1 Inhibitors Using Structure-Based Design.” Journal of Medicinal Chemistry, vol. 61, no. 6, Mar. 2018, pp. 2410–21. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.7b01155.

APA

Shaw, S., Bian, Z., Zhao, B., Tarr, J. C., Veerasamy, N., Jeon, K. O., Belmar, J., Arnold, A. L., Fogarty, S. A., Perry, E., Sensintaffar, J. L., Camper, D. V., Rossanese, O. W., Lee, T., Olejniczak, E. T., & Fesik, S. W. (2018). Optimization of Potent and Selective Tricyclic Indole Diazepinone Myeloid Cell Leukemia-1 Inhibitors Using Structure-Based Design. Journal of Medicinal Chemistry, 61(6), 2410–2421. https://doi.org/10.1021/acs.jmedchem.7b01155

Chicago

Shaw, Subrata, Zhiguo Bian, Bin Zhao, James C Tarr, Nagarathanam Veerasamy, Kyu Ok Jeon, Johannes Belmar, et al. 2018. “Optimization of Potent and Selective Tricyclic Indole Diazepinone Myeloid Cell Leukemia-1 Inhibitors Using Structure-Based Design.” Journal of Medicinal Chemistry 61 (6): 2410–21. doi:10.1021/acs.jmedchem.7b01155.